Featuring perspectives from Dr Srdan Verstovsek, including the following topics:
- Overview of current issues in the management of myeloproliferative neoplasms (MPN) (0:00)
- Treatment strategies for patients with myelofibrosis (MF) progressing after ruxolitinib (14:46)
- Correlation of molecular characterization and response to ruxolitinib in patients with MF (23:57)
- Rationale for and efficacy with combined inhibition of Bcl-2 and Bcl-xL for MPN (44:38)
- Targeting calreticulin mutations for MPN (52:02)
- Advances in the management of polycythemia vera (57:54)
- Developments in the care of patients with essential thrombocythemia (1:04:43)
- Future directions in the clinical care of patients with MPN (1:12:46)
CME information and select publications
Research To Practice | Oncology Videos